Tissue‐ and cell‐expression of druggable host proteins provide insights into repurposing drugs for <scp>COVID</scp> ‐19-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Tissue‐ and cell‐expression of druggable host proteins provide insights into repurposing drugs for COVID ‐19

Published:2022-10-19 Issue:12 Volume:15 Page:2796-2811
ISSN:1752-8054
Container-title:Clinical and Translational Science
language:en
Short-container-title:Clinical Translational Sci

Author:

Li Jiapeng¹^ORCID,Xue Yanling¹,Wang Xinwen²,Smith Logan S.¹,He Bing³,Liu Shuhan¹,Zhu Hao‐Jie¹^ORCID

Affiliation:

1. Department of Clinical Pharmacy University of Michigan College of Pharmacy Ann Arbor Michigan USA

2. Department of Pharmaceutical Sciences Northeast Ohio Medical University College of Pharmacy Rootstown Ohio USA

3. Department of Computational Medicine and Bioinformatics University of Michigan Ann Arbor Michigan USA

Publisher

Wiley

Subject

General Pharmacology, Toxicology and Pharmaceutics,General Biochemistry, Genetics and Molecular Biology,General Medicine,General Neuroscience

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/cts.13400

Reference111 articles.

1. The current landscape of coronavirus-host protein–protein interactions

2. Exploring the SARS-CoV-2 virus-host-drug interactome for drug repurposing

3. Mapping the SARS-CoV-2–Host Protein–Protein Interactome by Affinity Purification Mass Spectrometry and Proximity-Dependent Biotin Labeling: A Rational and Straightforward Route to Discover Host-Directed Anti-SARS-CoV-2 Therapeutics

4. Proteomics of SARS-CoV-2-infected host cells reveals therapy targets

5. A SARS-CoV-2 protein interaction map reveals targets for drug repurposing

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Differential Bioactivation Profiles of Different GS-441524 Prodrugs in Cell and Mouse Models: ProTide Prodrugs with High Cell Permeability and Susceptibility to Cathepsin A Are More Efficient in Delivering Antiviral Active Metabolites to the Lung;Journal of Medicinal Chemistry;2024-05-01

2. Recent Advancement in Anticancer Compounds from Marine Organisms: Approval, Use and Bioinformatic Approaches to Predict New Targets;Marine Drugs;2022-12-28

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3